Treatment Guide: Biologics for Psoriasis

Health & Lifestyle
371

Listen to article (english)

Translate to Spanish or other 102 languages!

As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. Image for illustration purposes
As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. Image for illustration purposes

Medical News Today

- Advertisement -

Biologics are injectable medications that pharmaceutical companies make from living cells in a lab or through a biological process. They change or stop specific cytokine activities inside immune cells that cause inflammation in psoriasis. 

As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. 

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/biologics-for-psoriasis?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-04-26&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Advance in the Treatment of Acute Heart Failure Identified
Next article
Driscoll Children’s Hospital Prepares for Grand Opening 

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The Silent Toll of Substance Use on Today’s Young Adults

Mega Doctor News by University of Michigan Newswise - Young adults who heavily use substances...
- Advertisement -